These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9284599)

  • 1. Adverse drugs reactions associated with glaucoma medications.
    Reyes E; Izquierdo NJ; Blasini M
    Bol Asoc Med P R; 1997; 89(4-6):51-5. PubMed ID: 9284599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact dermatitis to topical drugs for glaucoma.
    Holdiness MR
    Am J Contact Dermat; 2001 Dec; 12(4):217-9. PubMed ID: 11753897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of topical beta-blockers in glaucoma treatment.
    Goldberg I
    Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic keratopathy associated with beta-blocker eyedrops.
    Wilhelmus KR; McCulloch RR; Gross RL
    Cornea; 1990 Oct; 9(4):335-7. PubMed ID: 1981868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blockers in the treatment of open-angle glaucoma].
    Potocký M; Vodrázková E
    Cesk Slov Oftalmol; 1996 Nov; 52(6):399-402. PubMed ID: 9072217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirometry for patients prescribed topical beta-blockers.
    Snape JP; Waldock A
    Nurs Stand; 2000 Oct 11-17; 15(4):35-8. PubMed ID: 11971492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' guide to interactions between glaucoma and systemic medications.
    Gottfredsdottir MS; Allingham RR; Shields MB
    J Glaucoma; 1997 Dec; 6(6):377-83. PubMed ID: 9407366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic impact of new trends in glaucoma treatment.
    Marchetti A; Magar R; An P; Nichol M
    MedGenMed; 2001 Jul; 3(4):6. PubMed ID: 11549985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of topical antiglaucoma drugs on the ocular surface.
    Arici MK; Arici DS; Topalkara A; Güler C
    Clin Exp Ophthalmol; 2000 Apr; 28(2):113-7. PubMed ID: 10933774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
    Nenciu A; Stefan C; Ardelean C
    Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of glaucoma.
    Remis LL; Epstein DL
    Annu Rev Med; 1984; 35():195-205. PubMed ID: 6426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular conjunctivitis on Dipivefrin therapy for glaucoma.
    Coleiro JA; Sigurdsson H; Lockyer JA
    Eye (Lond); 1988; 2 ( Pt 4)():440-2. PubMed ID: 3253137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of glaucoma medications.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of levobunolol and dipivefrin for the treatment of glaucoma.
    Allen RC; Robin AL; Long D; Novack GD; Lue JC; Kaplan G
    Arch Ophthalmol; 1988 Jul; 106(7):904-7. PubMed ID: 3291837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.